Literature DB >> 15673543

Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era.

Axel Bauer1, Przemyslaw Guzik, Petra Barthel, Raphael Schneider, Kurt Ulm, Mari A Watanabe, Georg Schmidt.   

Abstract

AIMS: To test the prognostic value of ventricular late potentials (LPs) in a large cohort of post-infarction patients in the modern reperfusion era. METHODS AND
RESULTS: 1800 consecutive survivors of acute myocardial infarction in sinus rhythm and under 76 years of age were enrolled. Many (99%) of the patients received reperfusion/revascularization therapy (91% percutaneous coronary intervention) and up-to-date pharmacological treatment (99% aspirin, 93% beta-blockers, 90% ACE-inhibitors, and 85% statins). LPs were calculated in 968 patients and found to be present in 90 (9.3%). The primary endpoint was the composite of cardiac death and serious arrhythmic events. The secondary endpoint was the composite of sudden cardiac death and serious arrhythmic events. During follow-up (median 34 months), 26 patients reached the primary endpoint. The presence of LPs was not significantly associated with the primary endpoint in univariable or multivariable analysis. In contrast, low (< or = 30%) left ventricular ejection fraction (hazard ratio 9.6, 95% confidence interval 4.1-22.4), heart rate turbulence category 2 (7.5, 2.4-23.9) and category 1 (5.3, 1.9-14.9) were significant predictors in both univariable and multivariable analysis.
CONCLUSION: Ventricular LPs are of limited use for risk stratification in unselected post-infarction patients in the modern reperfusion era.

Entities:  

Mesh:

Year:  2005        PMID: 15673543     DOI: 10.1093/eurheartj/ehi101

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  11 in total

Review 1.  Electrocardiographic predictors of arrhythmic death.

Authors:  Michael G McLaughlin; Peter J Zimetbaum
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-10       Impact factor: 1.468

Review 2.  Sudden Cardiac Death Risk Stratification - An Update.

Authors:  Reginald Liew
Journal:  Eur Cardiol       Date:  2015-12

3.  Diagnostic utility of signal-averaged electrocardiography for detection of cardiac sarcoidosis.

Authors:  Joseph L Schuller; Christopher M Lowery; Matthew Zipse; Ryan G Aleong; Paul D Varosy; Howard D Weinberger; William H Sauer
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-01       Impact factor: 1.468

Review 4.  Surface Electrocardiogram Predictors of Sudden Cardiac Arrest.

Authors:  Samy A Abdelghani; Todd M Rosenthal; Daniel P Morin
Journal:  Ochsner J       Date:  2016

5.  Role of risk stratification after myocardial infarction.

Authors:  Vikas Kuriachan; Derek V Exner
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-02

Review 6.  Who should receive an implantable cardioverter-defibrillator after myocardial infarction?

Authors:  Stavros Mountantonakis; Mathew D Hutchinson
Journal:  Curr Heart Fail Rep       Date:  2009-12

7.  Effects of early losartan therapy on ventricular late potentials in acute myocardial infarction.

Authors:  Dae-Hyeok Kim; Woong-Gil Choi; Jun Kwan; Keum-Soo Park; Woo-Hyung Lee
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-10       Impact factor: 1.468

Review 8.  Noninvasive risk stratification after myocardial infarction: rationale, current evidence and the need for definitive trials.

Authors:  Derek Exner
Journal:  Can J Cardiol       Date:  2009-06       Impact factor: 5.223

9.  Terminal QRS Distortion in ST Elevation Myocardial Infarction as a Prediction of Mortality: Systematic Review and Meta-Analysis.

Authors:  Narut Prasitlumkum; Natee Sirinvaravong; Nath Limpruttidham; Pattara Rattanawong; Elysse Tom; Chanavuth Kanitsoraphan; Pakawat Chongsathidkiet; Thosaporn Boondarikpornpant
Journal:  Acta Cardiol Sin       Date:  2019-09       Impact factor: 2.672

10.  Heart rate turbulence as risk-predictor after myocardial infarction.

Authors:  Christine S Zuern; Petra Barthel; Axel Bauer
Journal:  Front Physiol       Date:  2011-12-12       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.